HIV Databases HIV Databases home HIV Databases home
HIV sequence database

An overview of the molecular phylogeny of lentiviruses


Brian T. Foley

T10, MS K710, Los Alamos National Laboratory, Los Alamos, NM 87545



Lentiviruses are one of several groups of retroviruses. In early studies of the molecular phylogenetic analysis of endogenous and exogenous retroviruses it was suggested that the retroviruses could be divided into four groups, two complex with several accessory or regulatory genes (lentiviruses; and the bovine and primate leukemia virus group now known as deltaretrovirus) and two simple, with just the gag, pol and env genes and few or no accessory genes (a group including spumaretroviruses, Ctype endogenous retroviruses and MMLV; the other group including Rous Sarcoma virus, HERV-K Simian Retrovirus 1 and MMTV) [1-5]. A more recent study, including many more recently discovered exogenous and endogenous retroviruses, illustrates the diversity of retroviruses [6]. The retroviridae are currently officially classified into seven different genera, according to the Seventh Report of the International Committee on Taxonomy of Viruses, 2000 ( The seven genera are named alpha through epsilon retroviruses plus lentiviruses and spumaviruses. Phylogenetic trees based on pol gene sequences can be found in several recent papers[6-8]. None of the retroviruses in either group of complex retroviruses have been found in an endogenous state to date.

Within the Lentiviruses, the primate lentiviruses discovered to date form a monophyletic cluster (Figure 1). One notable difference between the primate lentiviruses and the non-primate lentiviruses is that all nonprimate lentiviruses, except the BIV/JDV lineage, contain a region of the pol gene encoding a dUTPase, whereas all primate lentiviruses lack this region of pol. In the BIV/JDV lineage, an insert is still present in this region of pol, but the sequence similarity is low, and the region seems to be no longer capable of encoding a functional dUTPase. This lack of dUTPase, coupled with the distances between primate lentiviruses as compared to the distances between other mammalian lentiviruses, suggests that the lentiviruses originated in a non-primate mammal. A single transfer of virus from a non-primate mammal into primates was followed by spread of the virus into many different primate species. If the primate lentiviruses were older than the non-primate lentiviruses, one would expect greater diversity within the primate clade than between nonprimate clades. Feline immunodeficiency viruses have been studied from wild African lions [9], as well as North American wildcats [10], the Kazakhstan Pallas cat [11] and housecats from around the world [12]. The global diversity of feline immunodeficiency viruses is similar to the diversity of the primate lentiviruses. The global diversity of housecat FIVs is roughly twice as great as the diversity of the HIV-1 M group in humans. These facts indicate that domestic cats have been spreading FIV around the world for a longer period of time than humans have been spreading the HIV-1 M group, assuming that the two viral lineages evolve at close to equal rates.

Within the primate lentivirus group, each species and subspecies of primate seems to carry its own monophyletic lineage of lentivirus or to be free from lentiviral infection. Humans seem to not have their own lineage, but instead have acquired two very different lineages, named HIV-1 and HIV-2, from chimpanzees and sooty mangabeys, respectively. Baboons and macaques, like humans, seem only to acquire lentiviruses from other species and not have their own lineage[13-17]. The intra-species diversity in each lineage is not yet fully understood, because only one or a relatively small number of virus isolates from each species of primate have been sequenced to date. Primates and felines captured in distant geographic locations tend to have more diverse viral genotypes [12], whereas animals of the same species captured in proximity to one another tend to share similar genotypes of virus. Cross-species transmission of virus appears to be rare in comparison to within-species transmission, as evidenced by different primate

Figure 1. Phylogenetic Tree of Lentiviral pol and gag Genes.
A: The complete pol genes, including protease, reverse transcriptase, RNAse H and integrase coding regions of lentiviruses were aligned.
B: Nearly complete gag genes, from start codon to the end of the EIAV sequences near the Gag-Pol ribosomal slip site, were aligned. For both trees, columns containing gaps were removed (thus removing the dUTPase region from the Pol data) and the DNAdist and NEIGHBOR programs in the PHYLIP package were used. In DNAdist, the F84 (also called maximum likelihood) model of evolution was used with a transition/transversion ratio of 1.7. The trees were re-sized in TREETOOL so that they both have the same distance scale. The alignments used to build the trees are available from

species which share overlapping habitats and feline species which share overlapping habitats but each species carries its own lineage of virus. For example chimpanzee habitat overlaps African green monkey habitat, but there is no evidence of exchange of virus between chimpanzees and African green monkeys. Both interactions between the host animals and species restrictions of the viruses can contribute to cross-species transfer or lack of transfer. Likewise housecats all over the world appear to share a domestic cat FIV, rather than picking up FIVs from local wildcats. Examples of the relatively rare cross-species transmission events are noted in the literature. A Peruvian wildcat sampled in a zoo appeared to have picked up a domestic cat FIV in captivity [10]. A Japanese wildcat was infected with domestic cat FIV in the wild [18]. Humans are another notable example, having apparently picked up three lineages of virus from chimpanzees to create the HIV-1 M, N and O groups, and as many as seven lineages of virus from sooty mangabeys to create HIV-2 subtypes A though G [19-21]. Baboons, which are noted to lack their own strain of simian immunodeficiency virus, have repeatedly become infected from the vervet subspecies of African green monkeys with which they share habitats[13, 14]. Cross-species transmissions of visna and Caprine Arthritis-Encephalitis Virus (CAEV) between domestic goats and sheep are reported to be rather common [18, 22-26]. The SIVs from sooty mangabeys were also transferred into several species of macaques in captivity in the USA [15, 17, 27].

Molecular evolution of the lentiviruses

Lentiviruses have been estimated to mutate at a rate as much as 106 to 107 times the rate of mutations found in eukaryotic germ-line DNA [28, 29]. The rate of evolution of any region of a genome, viral or cellular, is a function of the spontaneous mutation rate, positive and negative selection pressures, and numbers of generations per unit of time upon which selection can act. Factors such as codon usage bias, methylation of CpG dinucleotides and nucleotide composition bias are examples of selective pressures that can contribute to the evolution rate. Lentiviruses not only mutate faster than eukaryotes, but also have vastly higher numbers of generations per unit time, and thus they are expected to, and are observed to, evolve at a much faster rate than eukaryotes [29]. One of the most recent estimates of the evolution rate of members of the HIV-1 M group is 0.0024 (0.0018 to 0.0028) substitutions per base pair per year in the env gp160 gene region and 0.0019 (0.0009 to 0.0027) substitutions per base pair per year in the gag gene region [30]. The deltaretroviruses, also known as T-cell leukemia viruses (TCLVs) [31], have many parallels to the lentiviruses. Both TCLVs and lentiviruses infect white blood cells. Both are complex retroviruses with regulatory genes in addition to the gag, pol and env genes found in all retroviruses. Both have made numerous cross species jumps from non-human primates into humans, and between non-human primate species [14, 32-36]. Both are found in non-primate mammals as well as in primates, with inter-primate distances less than inter-mammalian distances [6]. Neither has ever been found in an endogenous state in any mammal. It has therefore been of interest to compare and contrast these two classes of complex retroviruses.

Two recent papers have compared the molecular evolution of TCLVs and primate lentiviruses [29, 37]. The Wodarz paper [37] suggests that the large difference in evolution rate between the two viruses is primarily due to the ability of HIV-1, but not HTLV-I, to infect macrophages in addition to CD4+ T-helper cells. The Sala paper [29] suggests that the difference in rates of evolution between HIV-1 and HTLV-I is due to clonal expansion of HTLV-infected cells, versus active replication of HIV-1. The Wodarz paper specifically disagrees with the explanation offered by Sala. Neither paper addressed the issue of the difference in nucleotide composition between the TCLVs and lentiviruses. The lentiviruses are all A-rich and C-poor, with nucleic acid compositions of 36% A, 18% C, 24% G and 22% T. The A-richness and C-poorness is roughly evenly distributed across the lentiviral genomes, with the exception of bovine immunodeficiency-like virus and Jembrana disease virus, which both show a dramatic difference in nucleotide composition between the 5' and 3' halves of their genomes (Figure 2 panels A and B). The T-cell leukemia viruses are C-rich and G-poor with nucleic acid compositions of 23% A, 33% C, 18% G and 23% T, again with a relatively constant composition bias across the genome (Figure 2 panels C and D). Although Figure 2 uses a 500 base window to smooth out the nucleotide composition plots,

Figure 2. Nucleotide Composition of Lentiviruses and Deltaretroviruses. A Microsoft EXCEL spreadsheet was used to count the number of each base within a 500 base sliding window across each genome. In the top two panels, HIV-1 isolate B-HXB2 (K03455) is compared to bovine immunodeficiency virus isolate HXB3 (M32690) to illustrate the marked change in composition in the BLV genome. All other lentiviruses examined (FIV, Visna, CAEV, HIV-2, SIV-SMM, SIV-AGM) were A-rich across the genome, similar to HIV-1 (data not shown). In the lower panels, HTLV-I isolate CAR (D13784) and BLV isolate B19 (AF257515) are plotted for comparison to each other and to the lentiviral genomes.

smaller window sizes can be used to detect regions of the genome, such as the TAR element and the RRE, where RNA secondary structures require a more G+C-rich nucleotide composition bias. No biological reason for the difference in nucleotide base composition bias between the T-cell leukemia viruses and lentiviruses is apparent at this time. The fact that there is a striking difference suggests differences in the pattern of evolution as well as differences in rates of evolution between these two types of virus. Within the lentiviruses, the bovine viruses were exceptional in their nucleotide composition pattern across their genome (Figure 2), and also displayed nucleotide composition within the pol gene that differed from the other lentiviruses in being less A-rich (Figure 3).

The lentiviruses are extremely diverse in the DNA sequences of their genomes and the proteins encoded by them. Sala and Wain-Hobson point out that the amino acid sequence distance between the Pol protease peptides of HIV-1 and HIV-2 is roughly equivalent to the distance observed in homologous proteins from eubacteria and eukaryotes which last shared a common ancestor some 2 billion years ago [29]. The 106-fold faster rate of evolution in lentiviruses compared to those DNA genomes indicates that this diversity could have accumulated in closer to two thousand years than to two billion years. Any such speculations about the date of the most recent common ancestor of the primate lentiviruses are highly uncertain at this time, for numerous reasons. Korber et al. have shown that there is some uncertainty in the slope of the DNA sequence distances vs. time line even within the relatively closely related HIV-1 M group of primate lentiviruses [30]. They estimated that the HIV-1 M group of viruses last shared a common ancestor between 1915 and 1941 with a 95% confidence interval on the slope. Salemi et al. used a different method and arrived at a similar date for the origin of the HIV-1 M group. They further calculated that the common ancestor of the HIV-1 M group and the SIV-CPZs isolated from Pan troglodytes troglodytes dated to the late 17th century with a 99% confidence interval for a date between 1591 and 1761 [38]. The epidemiology of the AIDS pandemic tends to agree with a 20th century origin of the HIV-1 M group. The epidemic apparently went unnoticed in central sub-Saharan Africa for several decades [39]. Both the epidemiology and the molecular phylogenies of the HIV-1 O group and the HIV-2 viruses are less well understood than those of the HIV-1 M group. The nucleotide and amino acid sequence diversity of HIV-2 viruses is greater than the diversity of the HIV-1 M group viruses, but roughly equivalent to the diversity within the HIV-1/SIV-CPZ clade (Figure 1). The diverse HIV-2 lineages are thought to have arisen in sooty mangabeys, with several cross-species transfers from sooty mangabeys into humans, one for each subtype of HIV-2. The subtypes of HIV-2 are thus analogous to the groups (M, N and O) of HIV-1, both in terms of sequence diversity and in terms of the cross-species transfer events thought to have created them.

Figure 3. Nucleotide Composition of Lentivirus pol genes. The pol gene alignment used to produce the pol tree in figure 1 was analyzed for nucleotide composition. Each set of points (A, C, G and T) is for one viral sequence.

In any estimation of rates of evolution and times of divergence from common ancestors, an assumption that different lineages of the same organism evolve at similar rates greatly simplifies the calculations. A recent paper by Salemi et al. estimated that lineages of the HTLV-II virus evolves at a rate 150 to 350 times faster when the virus is transmitted between IV drug users, than lineages of the same virus propagated by mother-to-infant transmission [40]. Many studies of HIV-1 evolution in IV drug users and other communities have not turned up any such discrepancy in the rate of evolution of HIV-1 [41-44]. One study found that the rate of mutation of the env gene was 62% higher in frequent drug injectors, compared to those who had not injected drugs in the last 6 months [45]. Salemi et al. postulated that the increase in viral transmission rate between IV drug users, which can be many transmissions per year, accounted for the increase in HTLV-II evolution rate. HTLV-II mother to infant transmission would be expected to occur just once every 14 to 30 years for a given viral lineage. With HIV-1, both sexual and IV drug user transmissions can occur several times per year, and long-term chains of mother to infant transmission are never expected due to the lethality of HIV-infection in infants. In the rapidly expanding IV drug user epidemics that have been studied, no increase in HIV-1 evolution rate of needle-spread HIV1 compared to sexually transmitted HIV-1, has been noted [46-48].

Conserved elements in the lentiviral genome

Despite the rapid evolution rate of lentiviruses, many elements in the lentiviral genome have been conserved over time. One of the most conserved regions of the lentiviral genome is the Lys-tRNA primer binding site (PBS), where the host Lysine transfer RNA hybridizes to the viral RNA genome to serve as a primer for reverse transcription. The PBS is short, just 15 bases (GAACAGGGACUUGAA), but nearly perfectly conserved in all lentiviruses. It exists within a secondary structure element that is conserved in structure, but not sequence [49]. The polypurine tract, Rev-responsive element, Phi element, and other elements involved in replication and packaging of the viral genome are also conserved to varying degrees between all lentiviruses. The protein-coding regions of the genome are also conserved to varying degrees, with gag and pol being more conserved overall, than tat or env. Within the proteins, catalytic and/or functional domains are highly conserved. One such element is the C-X2-C-X4-H-X4-C zinc knuckle domain of the Gag p7 nucleocapsid peptide that binds to the psi element to specifically package the viral genome into budding virions [50]. Whenever two regions of the genome need to coevolve to retain the interaction between the two elements, such as Tat protein binding to the TAR element or Rev protein binding to the RRE element, the evolution rate of both regions is slowed.

The gag and pol genes of lentiviruses are conserved well enough that multiple sequence alignments of this region can be built with confidence. The env gene is much more variable, including many insertions and deletions, and even if the cysteines that form disulfide bonds to create the loop structures of the Env protein are aligned, one cannot be sure that the alignment is phylogenetically correct. Although the Env protein of the bovine immunodeficiency and Jembrana disease viruses display an aberrant nucleotide composition bias in comparison to the other lentiviruses, there is no evidence that this is due to recombination. A BLAST search of their env genes against the databases produces other lentiviral env genes as the most significant matches (Figure 2 and data not shown).

Although the linear sequence of nucleotides in the env genes or amino acids in the Env proteins are not highly conserved, the coiled-coil structure of the fusion domains of lentiviruses are conserved and share structural similarity with the fusion domains of other viral and host proteins [51-54]. Likewise, the structures of polymerases and proteases are conserved, as are key residues in catalytic sites [55-66]. A review of HIV protein structures was published in 1998 [67]. Likewise, although the lentiviruses display remarkable diversity in linear DNA sequences, the nucleotide composition bias appears to be constrained as shown in Figures 2 and 3.


[1] Doolittle, R.F. and D.F. Feng, Tracing the origin of retroviruses. Curr Top Microbiol Immunol, 1992. 176:195-211.

[2] Doolittle, R.F., et al., Origins and evolutionary relationships of retroviruses. Q Rev Biol, 1989. 64(1):1-30.

[3] Doolittle, R.F., et al., Retrovirus phylogeny and evolution. Curr Top Microbiol Immunol, 1990. 157:1-18.

[4] McClure, M.A., et al., Sequence comparisons of retroviral proteins: relative rates of change and general phylogeny. Proc Natl Acad Sci U S A, 1988. 85(8):2469-73.

[5] McClure, M.A., The complexities of genome analysis, the Retroid agent perspective. Bioinformatics, 2000. 16(2):79-95.

[6] Tristem, M., Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol, 2000. 74(8):3715-30.

[7] Herniou, E., et al., Retroviral diversity and distribution in vertebrates. J Virol, 1998. 72(7):5955-66.

[8] Tristem, M., et al., Three retroviral sequences in amphibians are distinct from those in mammals and birds. J Virol, 1996. 70(7):4864-70.

[9] Brown, E.W., et al., A lion lentivirus related to feline immunodeficiency virus: epidemiologic and phylogenetic aspects. J Virol, 1994. 68(9):5953-68.

[10] Carpenter, M.A., et al., Genetic and phylogenetic divergence of feline immunodeficiency virus in the puma (Puma concolor). J Virol, 1996. 70(10):6682-93.

[11] Barr, M.C., et al., Proviral organization and sequence analysis of feline immunodeficiency virus isolated from a Pallas' cat. Virology, 1997. 228(1):84-91.

[12] Carpenter, M.A., et al., Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat. Virology, 1998. 251(2):234-43.

[13] Jin, M.J., et al., Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol, 1994. 68(12):8454-60.

[14] van Rensburg, E.J., et al., Simian immunodeficiency viruses (SIVs) from eastern and southern Africa: detection of a SIVagm variant from a chacma baboon. J Gen Virol, 1998. 79(Pt 7):1809-14.

[15] Georges-Courbot, M.C., et al., Occurrence and frequency of transmission of naturally occurring simian retroviral infections (SIV, STLV, and SRV) at the CIRMF Primate Center, Gabon. J Med Primatol, 1996. 25(5):313-26.

[16] Voevodin, A., et al., Interspecies transmission of macaque simian T-cell leukemia/lymphoma virus type 1 in baboons resulted in an outbreak of malignant lymphoma. J Virol, 1996. 70(3):1633-9.

[17] Yokoyama, S., Molecular evolution of the human and simian immunodeficiency viruses. Mol Biol Evol, 1988. 5(6):645-59.

[18] Nishimura, Y., et al., Interspecies transmission of feline immunodeficiency virus from the domestic cat to the Tsushima cat (Felis bengalensis euptilura) in the wild. J Virol, 1999. 73(9):7916-21.

[19] Yamaguchi, J., S.G. Devare, and C.A. Brennan, Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res Human Retroviruses, 2000. 16(9):925-30.

[20] Chen, Z., et al., Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol, 1997. 71(5):3953-60.

[21] Chen, Z., et al., Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J Virol, 1996. 70(6):3617-27.

[22] Zanoni, R.G., Phylogenetic analysis of small ruminant lentiviruses. J Gen Virol, 1998. 79(Pt 8)(1):1951-61.

[23] Valas, S., et al., North American and French caprine arthritis-encephalitis viruses emerge from ovine maedi-visna viruses. Virology, 1997. 237(2):307-18.

[24] Leroux, C., et al., Genomic heterogeneity of small ruminant lentiviruses: existence of heterogeneous populations in sheep and of the same lentiviral genotypes in sheep and goats. Arch Virol, 1997. 142(6):1125-37.

[25] Karr, B.M., et al., Genetic characterization of two phenotypically distinct North American ovine lentiviruses and their possible origin from caprine arthritis-encephalitis virus. Virology, 1996. 225(1):1-10.

[26] Pasick, J., Maedi-visna virus and caprine arthritis-encephalitis virus: distinct species or quasispecies and its implications for laboratory diagnosis. Can J Vet Res, 1998. 62(4):241-4.

[27] Chakrabarti, L., et al., Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature, 1987. 328(6130):543-7.

[28] Ji, J. and L.A. Loeb, Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Virology, 1994. 199(2):323-30.

[29] Sala, M. and S. Wain-Hobson, Are RNA viruses adapting or merely changing? J Mol Evol, 2000. 51(1):12-20.

[30] Korber, B., et al., Timing the ancestor of the HIV-1 pandemic strains. Science, 2000. 288(5472):1789-96.

[31] Van Regenmortel, M.H.V.E., C.M.E. Fauquet, and D.H.I.E. Bishop, Virus Taxonomy: Classification and Nomenclature of Viruses: Seventh Report of the International Committee on Taxonomy of Viruses. 2000: Academic Press.

[32] Vandamme, A.M., et al., The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses. J Gen Virol, 1996. 77(Pt 5)(5):1089-99.

[33] Vandamme, A.M., M. Salemi, and J. Desmyter, The simian origins of the pathogenic human T-cell lymphotropic virus type I. Trends Microbiol, 1998. 6(12):477-83.

[34] Vandamme, A.M., et al., African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol, 1998. 72(5):4327-40.

[35] Vandamme, A.M., et al., Origins of HTLV-1 in South America. Nat. Med., 2000. 6(3):232-3.

[36] Voevodin, A., et al., Simian T-lymphotropic virus type 1 (STLV-1) infection in wild yellow baboons (Papio hamadryas cynocephalus) from Mikumi National Park, Tanzania. Virology, 1997. 228(2):350-9.

[37] Wodarz, D. and C.R. Bangham, Evolutionary dynamics of HTLV-I. J Mol Evol, 2000. 50(5):448-55.

[38] Salemi, M., et al., Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution. FASEB J., 2001. 15(2):276-278.

[39] Yusim, K., et al., Using HIV-1 sequences to infer historical features of the AIDS epidemics and HIV evolution. Phil. Trans. R. Soc. Lond. B, 2001. In Press.

[40] Salemi, M., et al., Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci U S A, 1999. 96(23):13253-8.

[41] Kuiken, C.L., et al., Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution. J Gen Virol, 1996. 77(Pt 4)(12):783-92.

[42] Kuiken, C.L., et al., Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the Amsterdam population. AIDS, 1996. 10(1):31-7.

[43] Kuiken, C., et al., Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am J Epidemiol, 2000. 152(9):814-22.

[44] Lukashov, V.V., et al., Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res Hum Retroviruses, 1996. 12(12):1179-83.

[45] Carneiro, M., et al., The effect of drug-injection behavior on genetic evolution of HIV-1. J Infect Dis, 1999. 180(4):1025-32.

[46] Oelrichs, R.B., et al., The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J Virol, 2000. 74(3):1149-57.

[47] Hernandez-Aguado, I., et al., Human immunodeficiency virus (HIV) infection in parenteral drug users: evolution of the epidemic over 10 years. Valencian Epidemiology and Prevention of HIV Disease Study Group. Int J Epidemiol, 1999. 28(2):335-40.

[48] Brown, A.J., et al., The molecular epidemiology of human immunodeficiency virus type 1 in six cities in Britain and Ireland. Virology, 1997. 235(1):166-77.

[49] Berkhout, B., Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol, 1996. 54(3):1-34.

[50] De Guzman, R.N., et al., Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science, 1998. 279(5349):384-8.

[51] Bentz, J., Membrane fusion mediated by coiled coils: a hypothesis. Biophys J, 2000. 78(2):886-900.

[52] Bentz, J. and A. Mittal, Deployment of membrane fusion protein domains during fusion. Cell Biol Int, 2000. 24(11):819-38.

[53] Weissenhorn, W., et al., Structural basis for membrane fusion by enveloped viruses. Mol Membr Biol, 1999. 16(1):3-9.

[54] Skehel, J.J. and D.C. Wiley, Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem, 2000. 69:531-69.

[55] Ding, J., et al., Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J Mol Biol, 1998. 284(4):1095-111.

[56] Huang, H., et al., Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science, 1998. 282(5394):1669-75.

[57] Georgiadis, M.M., et al., Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure, 1995. 3(9):879-92.

[58] Divita, G., et al., Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: a two step process. J Mol Biol, 1995. 245(5):508-21.

[59] Beard, W.A., et al., Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain. J Biol Chem, 1994. 269(45):28091-7.

[60] Yadav, P.N., et al., A computer-assisted analysis of conserved residues in the three-dimensional structures of the polymerase domains of Escherichia coli DNA polymerase I and HIV-1 reverse transcriptase. J Biol Chem, 1994. 269(1):716-20.

[61] Loya, S., et al., The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1. J Biol Chem, 1992. 267(20):13879-83.

[62] Kohlstaedt, L.A., et al., Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science, 1992. 256(5065):1783-90.

[63] Shih, C.K., et al., Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors. Proc Natl Acad Sci U S A, 1991. 88(21):9878-82.

[64] Piana, S. and P. Carloni, Conformational flexibility of the catalytic Asp dyad in HIV-1 protease: An ab initio study on the free enzyme. Proteins, 2000. 39(1):26-36.

[65] Hoog, S.S., et al., Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity. Biochemistry, 1996. 35(32):10279-86.

[66] York, D.M., et al., Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates. Environ Health Perspect, 1993. 101(3):246-50.

[67] Turner, B.G. and M.F. Summers, Structural biology of HIV. J Mol Biol, 1999. 285(1):1-32.

last modified: Tue May 7 13:34 2013

Questions or comments? Contact us at

Operated by Los Alamos National Security, LLC, for the U.S. Department of Energy's National Nuclear Security Administration
Copyright © 2005-2012 LANS LLC All rights reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health